Trial intelligence / Profile preview

PK of Entigin vs Baraclude in Healthy Adults

NCT02850848Phase 4Completed

Sponsor
Yung Shin Pharmaceutical Industry
Start
Dec 2015
Primary completion
Feb 2016
Modality
Small Molecules
01

Overview

A Phase 4 trial of entecavir in hepatitis B (HBV), sponsored by Yung Shin Pharmaceutical Industry. Started Dec 2015; status: completed.

02

Drugs

entecavir
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NCT02850848.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02850848.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call